Embark

Embark, founded in 2015 and headquartered in Massachusetts, is dedicated to developing new in vitro diagnostic methods for canine health issues. Embark is currently enhancing its canine DNA database to expand the scope of diagnosis and treatment, provide more convenient services for a larger number of dogs, and improve diagnostic accuracy.